Search results for: H. Mahravani
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 3

Search results for: H. Mahravani

3 In-situ Fabrication of Silver-PDMS Nanocomposite Membrane with Application in Olefine Separation

Authors: P. Tirgarbahnamiri, S. Mahravani, N. Haddadpour, F. Yaghmaie, F. Barazandeh

Abstract:

In this study, silver nanoparticle-Polydimethylsiloxane membrane (SNP-PDMS) was prepared with an in-situ reduction method using AgNO3 in poly (dimethylsiloxane) hardener. Optical and mechanical properties as well as functionality of these membranes were determined employing, UV-Vis spectrophotometry, FTIR, strain-stress test and liquid/liquid filtration measurements. Silver nanoparticles are known to selectively absorb Olefins and may be used for separation of Alkanes from olefins. Yellow color of silver nanocomposites and transparency of blank polymer were observed employing optical microscope. λmax in 415-420 nm regions in UV-Vis spectrophotometry are related to silver nanoparticles absorbance. Based on stress-strain test results, tensile strength of silver nanoparticle PDMS (SNP-PDMS) membranes is higher than PDMS films of comparable size and thickness. Moreover, permeability of SNP-PDMS membranes were characterized using similar olefin/paraffin pair using a simple bench scale separation set- up. The silver -PDMS membranes retain their color and UV-vis characteristics for extended periods of time exceeding several months.

Keywords: nanocomposite membrane, gas separation, facilitated transport, silver nanocomposite, PDMS, in-situ reduction

Procedia PDF Downloads 331
2 Neutralizing Antibody Response against Inactivated FMDV Type O/IRN/2010 Vaccine by Electron Beam in BALB/C Mice

Authors: F. Motamedi Sedeh, Sh. Chahardoli, H. Mahravani, N. Harzandi, M. Sotoodeh, S. K. Shafaei

Abstract:

Foot-and-mouth disease virus (FMDV) is the most economically important disease of livestock. The aim of the study is inactivation of FMD virus type O/IRN/2010 by electron beam without antigenic changes as electron radio vaccine. The BALB/C mice were divided into three groups, each group containing five mice. Three groups of mice were inoculated with conventional vaccine and electron beam irradiated vaccine FMDV type O/IRN/2010 subcutaneously three weeks interval, the final group as negative control. The sera were separated from the blood samples of mice 14 days after last vaccination and tested for the presence of antibodies against FMDV type O/IRN/2010 by serum neutralization test. The Serum Neutralization Test (SNT) was carried out and antibody titration was calculated according to the Kraber protocol. The results of the SNT in three groups of mice showed the titration of neutralizing antibody in the vaccinated mice groups; electron radio vaccine and conventional vaccine were significantly higher than negative control group (P<0.05). Therefore, the radio vaccine is a good candidate to immunize animals against FMDV type O/IRN/2010.

Keywords: FMDV type O/IRN/2010, neutralizing antibody response, electron beam, radio vaccine

Procedia PDF Downloads 316
1 Evaluation of Immune Responses of Gamma-Irradiated, Electron Beam Irradiated FMD Virus Type O/IRN/2007 Vaccines and DNA Vaccine- Based on the VP1 Gene by a Prime-Boost Strategy in a Mouse Model

Authors: Farahnaz Motamedi Sedeh, Homayoon Mahravani, Parvin Shawrang, Mehdi Behgar

Abstract:

Most countries use inactivated binary ethylenimine (BEI) vaccines to control and prevent Foot-and-Mouth Disease (FMD). However, this vaccine induces a short-term humoral immune response in animals. This study investigated the cellular and humoral immune responses in homologous and prime-boost (PB) groups in the BALB/c mouse model. FMDV strain O/IRN/1/2007 was propagated in the BHK-21 cell line and inactivated by three methods, including a chemical with BEI to produce a conventional vaccine (CV), a gamma irradiation vaccine (GIV), and an electron irradiated vaccine (EIV). Three vaccines were formulated with the adjuvant aluminum hydroxide gel. In addition, a DNA vaccine was prepared by amplifying the virus VP1 gene pcDNA3.1 plasmid. In addition, the plasmid encoding the granulocyte-macrophage colony-stimulating factor gene (GM-CSF) was used as a molecular adjuvant. Eleven groups of five mice each were selected, and the vaccines were administered as homologous and heterologous strategy prime-boost (PB) in three doses two weeks apart. After the evaluation of neutralizing antibodies, interleukin (IL)-2, IL-4, IL-10, interferon-gamma (INF-γ), and MTT assays were compared in the different groups. The pcDNA3.1+VP1 cassette was prepared and confirmed as a DNA vaccine. The virus was inactivated by gamma rays and electron beams at 50 and 55 kGy as GIV and EIV, respectively. Splenic lymphocyte proliferation in the inactivated vaccinated homologous groups was significantly lower (P≤0.05) compared with the heterologous prime-boosts (PB1, PB2, PB3) and DNA + GM-CSF groups (P≤0.05). The highest SNT titer was observed in the inactivated vaccine groups. IFN-γ and IL-2 were higher in the vaccinated groups. It was found that although there was a protective humoral immune response in the groups with inactivated vaccine, there was adequate cellular immunity in the group with the DNA vaccine. However, the strongest cellular and humoral immunity was observed in the PB groups. The primary injection was accompanied by DNA vaccine + GM-CSF and boosted injection with GIV or CV.

Keywords: foot and mouth disease, irradiated vaccine, immune responses, DNA vaccine, prime boost strategy

Procedia PDF Downloads 16